Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.

Saved in:
Bibliographic Details
Title: Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.
Authors: Von Roemeling CA; University of Florida Gainesville, FL United States., Doonan BP; Mayo Clinic United States., Carpenter SL; University of Florida Gainesville, FL United States., Patel JA; University of Florida Gainesville, FL United States., Jobin GW; University of Florida Gainesville, FL United States., Yang C; Preston A. Wells, Jr. Center for Brain Tumor Therapy, UF Brain Tumor Immunotherapy Program, University of Florida Gainesville, FL United States., Bhatia A; University of Florida Gainesville, FL United States., Trivedi V; University of Florida Gainesville, FL United States., Acevedo A; University of Florida United States., Elliott T; University of Florida Gainesville, FL United States., Archibald V; University of Florida United States., Speakman SM; University of Florida Gainesville, FL United States., Matich E; National Cancer Institute Frederick, Maryland United States., Mitchell DA; University of Florida Gainesville, FL United States.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-25-0349